Astria Therapeutics, Inc. (ATXS)
NASDAQ: ATXS · Real-Time Price · USD
9.50
-0.08 (-0.83%)
Nov 21, 2024, 11:49 AM EST - Market open
Astria Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
59
Market Cap
536.13M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Auna S.A. | 1.10B |
Organogenesis Holdings | 455.04M |
Pharming Group | 285.75M |
Fulgent Genetics | 277.76M |
SI-BONE | 157.04M |
Silence Therapeutics | 21.77M |
Mereo BioPharma Group | 1.00M |
Opthea | 261.86K |
ATXS News
- 7 days ago - Astria Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update - Business Wire
- 8 days ago - Astria Therapeutics to Present at Upcoming Jefferies London Healthcare Conference - Business Wire
- 16 days ago - Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 22 days ago - Astria Therapeutics to Present at Upcoming Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting - Business Wire
- 4 weeks ago - Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting - Business Wire
- 5 weeks ago - European Commission Grants Orphan Medicinal Product Designation for Navenibart, Astria Therapeutics' Investigational Therapy for the Treatment of Hereditary Angioedema - Business Wire
- 7 weeks ago - Astria Therapeutics Receives FDA Orphan Drug Designation for Navenibart (STAR-0215) for the Treatment of Hereditary Angioedema - Business Wire
- 7 weeks ago - Astria Therapeutics to Present at Upcoming Global Angioedema Forum - Business Wire